C D A Stehouwer

Author PubWeight™ 138.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010 11.55
2 Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008 7.84
3 The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007 3.81
4 The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 2010 2.33
5 Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003 2.28
6 Diabetes, prediabetes and cancer mortality. Diabetologia 2010 2.22
7 Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia 2005 2.16
8 Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res 2013 2.01
9 [Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd 2008 1.94
10 In-training assessment: qualitative study of effects on supervision and feedback in an undergraduate clinical rotation. Med Educ 2006 1.56
11 Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens 2004 1.51
12 Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2008 1.50
13 Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005 1.46
14 Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. J Hum Hypertens 2005 1.45
15 Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) 2003 1.43
16 Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia 2011 1.42
17 Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Neth J Med 2010 1.42
18 Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2005 1.40
19 Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med 2002 1.38
20 Effectiveness of clinical rotations as a learning environment for achieving competences. Med Teach 2004 1.35
21 Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2008 1.29
22 Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003 1.28
23 Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int 2008 1.23
24 Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 2009 1.22
25 The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med 2004 1.21
26 Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med 2013 1.20
27 Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med 2007 1.14
28 The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord 2002 1.13
29 [Guideline 'Cardiovascular Risk Management']. Ned Tijdschr Geneeskd 2007 1.11
30 Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 2004 1.09
31 [Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands: at least 65,000 per year in the age group of 50 years and above]. Ned Tijdschr Geneeskd 2003 1.08
32 Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study. Diabetologia 2009 1.06
33 Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med 2007 1.06
34 Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Diabetologia 2004 1.06
35 Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab 2013 1.04
36 [Microvascular dysfunction as an explanation for the metabolic syndrome]. Ned Tijdschr Geneeskd 2005 1.04
37 [Finnish questionnaire reasonably good predictor of the incidence of diabetes in The Netherlands]. Ned Tijdschr Geneeskd 2008 1.01
38 Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. Eur J Clin Invest 2002 1.01
39 Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur J Endocrinol 2008 0.99
40 Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab 2007 0.98
41 Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract 2008 0.97
42 Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) 2002 0.97
43 Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr 2013 0.97
44 Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005 0.96
45 Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans 2003 0.96
46 Mild-to-moderate renal impairment is associated with platelet activation: a cross-sectional study. Clin Nephrol 2008 0.95
47 Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training. Eur J Endocrinol 2008 0.95
48 Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med 2005 0.95
49 Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Invest 2003 0.94
50 Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest 2002 0.94
51 Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 2006 0.94
52 Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 - 5 chronic kidney disease. Clin Nephrol 2009 0.94
53 Ethnic comparison of the association of undiagnosed diabetes with obesity. Int J Obes (Lond) 2009 0.93
54 Vitamin D in relation to myocardial structure and function after eight years of follow-up: the Hoorn study. Ann Nutr Metab 2012 0.92
55 Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest 2002 0.91
56 Complement C3: an emerging risk factor in cardiometabolic disease. Diabetologia 2012 0.91
57 Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. Diabetologia 2013 0.91
58 High prevalence of diabetes mellitus in patients with liver cirrhosis. Diabet Med 2010 0.91
59 Maternal smoking during pregnancy and childhood overweight and fat distribution: the KOALA Birth Cohort Study. Pediatr Obes 2013 0.91
60 Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study. J Clin Endocrinol Metab 2013 0.91
61 Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. J Intern Med 2004 0.91
62 Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study. Atherosclerosis 2011 0.90
63 Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr 2005 0.89
64 Metformin-associated lactic acidosis in a patient with normal kidney function. Diabetes Res Clin Pract 2011 0.88
65 Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study. Nutr Metab Cardiovasc Dis 2012 0.88
66 Feasibility and reliability of an in-training assessment programme in an undergraduate clerkship. Med Educ 2004 0.88
67 Modulation of insulin action by advanced glycation endproducts: a new player in the field. Horm Metab Res 2008 0.87
68 A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study. Diabetologia 2003 0.87
69 Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2013 0.87
70 Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis. Atherosclerosis 2005 0.86
71 Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2013 0.86
72 No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Neth J Med 2004 0.86
73 Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study. J Endocrinol Invest 2010 0.85
74 The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1. Diabetologia 2013 0.85
75 Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. J Intern Med 2013 0.84
76 Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial. Diabetologia 2010 0.84
77 LDL oxidative modifications in well- or moderately controlled type 2 diabetes. Diabetes Metab Res Rev 2004 0.84
78 Adherence to a Mediterranean dietary pattern in early life is associated with lower arterial stiffness in adulthood: the Amsterdam Growth and Health Longitudinal Study. J Intern Med 2012 0.84
79 Current and adolescent levels of cardiopulmonary fitness are related to large artery properties at age 36: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Invest 2002 0.84
80 Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J Clin Endocrinol Metab 2012 0.84
81 Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study. Atherosclerosis 2003 0.83
82 Global clinical performance rating, reliability and validity in an undergraduate clerkship. Neth J Med 2005 0.83
83 Relationship between body mass index and mortality among Europeans. Eur J Clin Nutr 2011 0.82
84 Predicting mortality of psychogeriatric patients: a simple prognostic frailty risk score. Postgrad Med J 2009 0.82
85 Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study. Nutr Metab Cardiovasc Dis 2012 0.82
86 Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study. Diabetologia 2012 0.82
87 Multidisciplinary structured lifestyle intervention reduces the estimated risk of cardiovascular morbidity and mortality. Neth Heart J 2004 0.81
88 Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. Neth J Med 2008 0.81
89 Evaluation of the one-minute exercise test to detect peripheral arterial disease. Eur J Clin Invest 2008 0.81
90 Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes. J Intern Med 2003 0.81
91 Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women. J Intern Med 2002 0.80
92 Effects of hormone replacement therapy on blood platelets. Eur J Clin Invest 2002 0.80
93 The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study. J Hum Hypertens 2009 0.80
94 Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study. Eur J Clin Nutr 2007 0.80
95 Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two Caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2013 0.79
96 S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations. Eur J Clin Invest 2003 0.79
97 Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. Eur J Clin Invest 2003 0.79
98 Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study. J Intern Med 2005 0.79
99 The association between birth weight and plasma fibrinogen is abolished after the elimination of genetic influences. J Thromb Haemost 2003 0.79
100 Effects of an in-training assessment programme on supervision of and feedback on competencies in an undergraduate Internal Medicine clerkship. Med Teach 2005 0.78
101 Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study. J Clin Endocrinol Metab 2014 0.78
102 No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. Clin Endocrinol (Oxf) 2006 0.78
103 Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin. Neth J Med 2003 0.78
104 Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension. J Hum Hypertens 2006 0.78
105 Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin? Diabet Med 2005 0.77
106 S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study. Arterioscler Thromb Vasc Biol 2005 0.77
107 Albuminuria and cognitive functioning in an older population: the Hoorn study. Dement Geriatr Cogn Disord 2011 0.77
108 [6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults. Eur J Clin Nutr 2005 0.77
109 Dietary polyunsaturated fat intake is associated with low-density lipoprotein size, but not with susceptibility to oxidation in subjects with impaired glucose metabolism and type II diabetes: the Hoorn study. Eur J Clin Nutr 2006 0.77
110 Excess cardiovascular risk in diabetic women: a case for intensive treatment. Curr Hypertens Rep 2015 0.77
111 Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial. Eur J Clin Invest 2004 0.76
112 Comment on: Schmidt MI, Duncan BB, Vigo A et al (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086-2096. Diabetologia 2006 0.76
113 Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study. Diabet Med 2007 0.76
114 Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score. Int J Cardiol 2004 0.76
115 Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial. Thromb Haemost 2002 0.76
116 Epidemiology of homocysteine as a risk factor in diabetes. Metab Syndr Relat Disord 2003 0.76
117 Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study. J Nutr Health Aging 2016 0.76
118 Risk scores for predicting type 2 diabetes: using the optimal tool. Diabetologia 2011 0.75
119 The diagnosis of non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012 0.75
120 A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 2003 0.75
121 Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women. J Intern Med 2003 0.75
122 Divergent paradigm shifts in national, European and American cardiovascular prevention guidelines. Neth J Med 2014 0.75
123 Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS. Hum Reprod 2011 0.75
124 [Premature cardiovascular disease: no indication for the determination of antiphospholipid antibodies or lupus anticoagulant as a possible risk factor]. Ned Tijdschr Geneeskd 2007 0.75
125 Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study. Diabet Med 2008 0.75
126 [Old and new scoring systems for assessing cardiovascular risks: problems with the validity, the precision and the homogenicity of the risk categories]. Ned Tijdschr Geneeskd 2004 0.75
127 Associations of serum n-3 and n-6 polyunsaturated fatty acids with echocardiographic measures among older adults: the Hoorn Study. Eur J Clin Nutr 2013 0.75
128 Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study. Diabetologia 2013 0.75
129 Biomarker research in glucose disorders: current concepts and clinical applications. J Diabetes Res 2013 0.75